Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment
- PMID: 35811360
- PMCID: PMC9271711
- DOI: 10.3904/kjim.2021.543
Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment
Abstract
The Korean Society of Nephrology (KSN) has published a clinical practice guideline (CPG) document for maintenance hemodialysis (HD). The document, 2021 Clinical Practice Guideline on Optimal HD Treatment, is based on an extensive evidence-oriented review of the benefits of preparation, initiation, and maintenance therapy for HD, with the participation of representative experts from the KSN under the methodologists' support for guideline development. It was intended to help clinicians participating in HD treatment make safer and more effective clinical decisions by providing user-friendly guidelines. We hope that this CPG will be meaningful as a recommendation in practice, but not on a regulatory rule basis, as different approaches and treatments may be used by health care providers depending on the individual patient's condition. This CPG consists of eight sections and 15 key questions. Each begins with statements that are graded by the strength of recommendations and quality of the evidence. Each statement is followed by a summary of the evidence supporting the recommendations. There are also a link to full-text documents and lists of the most important reports so that the readers can read further (most of this is available online).
Keywords: Evidence-based practice; GRADE approach; Hemodialysis units, hospital; Practice guideline.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
The Work Group has been making the best efforts to avoid any actual and potential conflicts of interest to ensure a neutral and fair process in guideline development. All members of the Work Group obtained a conflict-of-interest disclosure form before participating in the development of the CPG and when completing the CPG to determine whether there was a financial or non-financial conflict of interest. In the case of reports of corporate research sponsorship or consulting, detailed report contents were confirmed after review by the Work Group. To determine whether the amount of money and the content of the recommendation can be affected, and if an amount exceeding the standard may affect the content of the recommendation, we recommend that the opinion of the relevant member be excluded when determining the direction and strength of the recommendation. This principle was applied from the beginning to the end of the development.
The full text version of this CPG is available on the KSN website (
Similar articles
-
Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.Kidney Res Clin Pract. 2021 Dec;40(4):578-595. doi: 10.23876/j.krcp.21.700. Epub 2021 Dec 10. Kidney Res Clin Pract. 2021. PMID: 34922430 Free PMC article.
-
Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia.Korean J Intern Med. 2022 Nov;37(6):1120-1137. doi: 10.3904/kjim.2022.174. Epub 2022 Oct 17. Korean J Intern Med. 2022. PMID: 36245341 Free PMC article. Review.
-
Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia.Kidney Res Clin Pract. 2022 Jul;41(4):393-411. doi: 10.23876/j.krcp.33.555. Epub 2022 Jul 28. Kidney Res Clin Pract. 2022. PMID: 35919925 Free PMC article.
-
Korean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of Hyponatremia.Electrolyte Blood Press. 2022 Jun;20(1):21-38. doi: 10.5049/EBP.2022.20.1.21. Epub 2022 Jun 30. Electrolyte Blood Press. 2022. PMID: 36451712 Free PMC article. Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
Cited by
-
Which blood pressure metrics should be used in patients on dialysis?Kidney Res Clin Pract. 2024 Mar;43(2):133-142. doi: 10.23876/j.krcp.23.126. Epub 2023 Nov 14. Kidney Res Clin Pract. 2024. PMID: 38062622 Free PMC article.
References
-
- Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363:609–619. - PubMed
-
- Collins J, Cooper B, Branley P, et al. Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial. Contrib Nephrol. 2011;171:1–9. - PubMed
-
- Harris A, Cooper BA, Li JJ, et al. Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis. 2011;57:707–715. - PubMed
-
- Whalley GA, Marwick TH, Doughty RN, et al. Effect of early initiation of dialysis on cardiac structure and function: results from the echo substudy of the IDEAL trial. Am J Kidney Dis. 2013;61:262–270. - PubMed
-
- Korevaar JC, Jansen MA, Dekker FW, et al. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet. 2001;358:1046–1050. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical